Cargando…

Redox control of β(2)-glycoprotein I–von Willebrand factor interaction by thioredoxin-1

Background:β(2)-Glycoprotein I (β(2)GPI) is an abundant plasma protein that is closely linked to blood clotting, as it interacts with various protein and cellular components of the coagulation system. However, the role of β(2)GPI in thrombus formation is unknown. We have recently shown that β(2)GPI...

Descripción completa

Detalles Bibliográficos
Autores principales:	PASSAM, F H, RAHGOZAR, S, QI, M, RAFTERY, M J, WONG, J W H, TANAKA, K, IOANNOU, Y, ZHANG, J Y, GEMMELL, R, QI, J C, GIANNAKOPOULOS, B, HUGHES, W E, HOGG, P J, KRILIS, S A
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Coagulation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017748/ https://www.ncbi.nlm.nih.gov/pubmed/20979592 http://dx.doi.org/10.1111/j.1538-7836.2010.03944.x

Ejemplares similares

Plasma free fatty acid levels influence Zn(2+)-dependent histidine-rich glycoprotein–heparin interactions via an allosteric switch on serum albumin
por: Kassaar, O, et al.
Publicado: (2015)

The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit
por: Hethershaw, E. L., et al.
Publicado: (2018)

Myeloid but not epithelial tissue factor exerts protective anti‐inflammatory effects in acid aspiration‐induced acute lung injury
por: Kral‐Pointner, J. B., et al.
Publicado: (2017)

A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
por: TAI, S J, et al.
Publicado: (2008)

Androgen receptor dampens tissue factor expression via nuclear factor‐κB and early growth response protein 1
por: Hoesel, B., et al.
Publicado: (2018)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model
por: SU, E J, et al.
Publicado: (2011)

Dexamethasone inhibits endotoxin‐induced coagulopathy in human lungs
por: Bartko, J., et al.
Publicado: (2016)

Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion protein
por: PETERS, R T, et al.
Publicado: (2013)

Coagulation factor XII protease domain crystal structure
por: Pathak, M, et al.
Publicado: (2015)

Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
por: Healey, J. F., et al.
Publicado: (2018)

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
por: Nguyen, G. N., et al.
Publicado: (2016)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Genomeâwide analysis of genetic determinants of circulating factorÂVIIâactivating protease (FSAP) activity
por: Olsson, M., et al.
Publicado: (2018)

Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation
por: Hamad, B. K., et al.
Publicado: (2017)

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays
por: Horn, C., et al.
Publicado: (2018)

Factor XII truncation accelerates activation in solution
por: de Maat, S., et al.
Publicado: (2018)

Towards patient‐specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry
por: Juffermans, Nicole P., et al.
Publicado: (2019)

Novel, high incidence exercise-induced muscle bleeding model in hemophilia B mice: rationale, development and prophylactic intervention
por: Tranholm, M, et al.
Publicado: (2015)

An engineered U1 small nuclear RNA rescues splicing-defective coagulation F7 gene expression in mice
por: Balestra, D, et al.
Publicado: (2014)

A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles
por: Arraud, N, et al.
Publicado: (2015)

Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity
por: South, K., et al.
Publicado: (2016)

Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease
por: Baker, Stephen R., et al.
Publicado: (2019)

Crosslinked clots formed independently of factor XIII and without fibrinogen‐to‐fibrin conversion – is this a liver‐specific phenomenon?
por: Lisman, T.
Publicado: (2018)

Sirtilins – the new old members of the vitamin K‐dependent coagulation factor family
por: Dahms, Sven O., et al.
Publicado: (2019)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Βeta 2-glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner
por: El-Assaad, Fatima, et al.
Publicado: (2017)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Autoregulation of von Willebrand factor function by a disulfide bond switch
por: Butera, Diego, et al.
Publicado: (2018)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation?: A Systematic Review and Field Synopsis of 23 Factors in 32 Population-Based Cohorts of 20 Million Participants
por: Allan, Victoria, et al.
Publicado: (2017)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
por: Xie, Lijuan, et al.
Publicado: (2001)

Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study
por: Rahgozar, Soheila, et al.
Publicado: (2015)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
por: El-Assaad, Fatima, et al.
Publicado: (2016)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ijihf2rppnof5561f8pbg0i86e